New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Acurx Pharmaceuticals, Inc.
ACXP
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

30M

Biotechnology

Next Earning date - 13 Nov 2024

30M

Biotechnology

Next Earning date - 13 Nov 2024

1.86USD
Shape-0.04 ( -2.11%)
favorite-chart

Relative Strenght

20
favorite-chart

Volume Buzz

-6%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

67%

Quote Panel

Shape
Updated October 25, 2024
1W -6.12 % 1M -6.60 % 3M -19.30 % 1Y -61.02 %

Key Metrics

Shape
  • Market Cap

    30.22M


  • Shares Outstanding

    16.25M


  • Share in Float

    13.84M


  • Dividende

    0


  • Earning Date

    13 Nov 2024


  • Price Target

    1.86


  • Average Volume

    49296


  • Beta

    -1.733


  • Range

    1.52-5.7


  • Industry

    Biotechnology


  • Website

    https://www.acurxpharma.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

0.00x

P/S Ratio

8.69x

P/B Ratio

0.0

Debt/Equity

0.0%

Net Margin

$-1.1

EPS

How ACXP compares to sector?

P/E Ratio

Relative Strength

Shape

ACXP

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$10M

ShapeNaN%

2025-Revenue

$1.52

Shape-487%

2025-EPS

0

Analyst rating

No Data Available

Last analyst upgrade/downgrade

No Data Available

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-0.32
vs -0.46

Q4.22

arrow
arrow

N/A

-0.28
vs -0.23

Q1.23

arrow
arrow

N/A

-0.25
vs -0.26

Q2.23

arrow
arrow

N/A

-0.28
vs -0.26

Q3.23

arrow
arrow

N/A

-0.24
vs -0.32

Q4.23

arrow
arrow

N/A

-0.38
vs -0.28

Q1.24

arrow
arrow

N/A

-0.28
vs -0.25

Q2.24

arrow
arrow

N/A

-0.26
vs -0.28

Q3.24

arrow
arrow

N/A

-0.14
vs -0.24

Q4.24

arrow
arrow

N/A

-0.14
vs -0.38

Sales GrowthShape

status-upYoY

Current

Estimates

Q1.22

arrow
arrow

NA

NA  vs NA

Q2.22

arrow
arrow

NA

NA  vs NA

Q3.22

arrow
arrow

NA

NA  vs NA

Q4.22

arrow
arrow

NA

NA  vs NA

Q1.23

arrow
arrow

NA

NA  vs NA

Q2.23

arrow
arrow

NA

NA  vs NA

Q3.23

arrow
arrow

NA

NA  vs NA

Q4.23

arrow
arrow

NA

NA  vs NA

Q1.24

arrow
arrow

NA

NA  vs NA

Q2.24

arrow
arrow

NA

NA  vs NA

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-36%

-0.36
vs -0.30

Q4.22

arrow
arrow

+28%

0.28
vs -0.36

Q1.23

arrow
arrow

-55%

-0.55
vs 0.28

Q2.23

arrow
arrow

-55%

-0.55
vs -0.55

Q3.23

arrow
arrow

-79%

-0.79
vs -0.55

Q4.23

arrow
arrow

-110%

-1.10
vs -0.79

Q1.24

arrow
arrow

-73%

-0.73
vs -1.10

Q2.24

arrow
arrow

-120%

-1.20
vs -0.73

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

12

12
vs 11

9%

Q4.22

arrow
arrow

14

14
vs 12

17%

Q1.23

arrow
arrow

12

12
vs 14

-14%

Q2.23

arrow
arrow

12

12
vs 12

NA

Q3.23

arrow
arrow

17

17
vs 12

42%

Q4.23

arrow
arrow

25

25
vs 17

47%

Q1.24

arrow
arrow

27

27
vs 25

8%

Q2.24

arrow
arrow

26

26
vs 27

-4%

Earnings Growth

Latest News